Improved Methods for Reprogramming Human Dermal Fibroblasts Using Fluorescence Activated Cell Sorting

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Kahler, David J ^a   Ahmad, Faizzan S ^a,b   Ritz, Anita ^a   Hua, Haiqing ^a,c   Moroziewicz, Dorota N ^a   Sproul, Andrew A ^a   Dusenberry, Carmen R ^a   Shang, Linshan ^a   Paull, Daniel ^a   Zimmer, Matthew ^a   Weiss, Keren A ^a   Egli, Dieter ^a   Noggle, Scott A ^a  

^a New York Stem Cell Foundation   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSOMAL AMINOPEPTIDASE; PODOCALYXIN; RETROVIRUS VECTOR; STAGE SPECIFIC EMBRYO ANTIGEN 4;

ADULT; ANIMAL CELL; ARTICLE; CELL ISOLATION; EMBRYO; FEMALE; FIBROBLAST CULTURE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; RETROVIRUS; SENDAI VIRUS; SINGLE CELL ANALYSIS; SKIN BIOPSY; SKIN FIBROBLAST; TOTAL QUALITY MANAGEMENT; VIRUS INFECTION;

ADULT; ANIMALS; BIOPSY; CELL DIFFERENTIATION; CELL SEPARATION; CELLS, CULTURED; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; KARYOTYPING; MALE; MICE; MIDDLE AGED; NUCLEAR REPROGRAMMING; SKIN; TERATOMA; TIME FACTORS;

SENDAI VIRUS;

EID: 84875491866     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059867     Document Type: Article

References (19)

1. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
2. Kiskinis E, Eggan K, (2010) Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 120: 51-59.
3. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, et al. (2009) Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461: 402-406.
4. Maehr R, Chen S, Snitow M, Ludwig T, Yagasaki L, et al. (2009) Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A 106: 15768-15773.
5. Zhu S, Li W, Zhou H, Wei W, Ambasudhan R, et al. (2010) Reprogramming of Human Primary Somatic Cells by OCT4 and Chemical Compounds. Cell stem cell 7: 651-655.
6. Inoue H, Yamanaka S, (2011) The Use of Induced Pluripotent Stem Cells in Drug Development. Clin Pharmacol Ther 89(5): 655-661.
7. Smith ZD, Nachman I, Regev A, Meissner A, (2010) Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat Biotechnol 28: 521-526.
8. Sorrell JM, Baber MA, Brinon L, Carrino DA, Seavolt M, et al. (2003) Production of a monoclonal antibody, DF-5, that identifies cells at the epithelial-mesenchymal interface in normal human skin. APN/CD13 is an epithelial-mesenchymal marker in skin. Exp Dermatol 12: 315-323.
9. Chan EM, Ratanasirintrawoot S, Park IH, Manos PD, Loh YH, et al. (2009) Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27: 1033-1037.
10. Valamehr B, Abujarour R, Robinson M, Le T, Robbins D, et al. (2012) A novel platform to enable the high-throughput derivation and characterization of feeder-free human iPSCs. Sci Rep 2: 213.
11. Noggle S, Fung HL, Gore A, Martinez H, Satriani KC, et al. (2011) Human oocytes reprogram somatic cells to a pluripotent state. Nature 478: 70-75.
12. Boulting GL, Kiskinis E, Croft GF, Amoroso MW, Oakley DH, et al. (2011) A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 29: 279-286.
13. Lin T, Ambasudhan R, Yuan X, Li W, Hilcove S, et al. (2009) A chemical platform for improved induction of human iPSCs. Nat Methods 6: 805-808.
14. Pruszak J, Sonntag KC, Aung MH, Sanchez-Pernaute R, Isacson O, (2007) Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells 25: 2257-2268.
15. Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, et al. (2011) Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144: 439-452.
16. Sundberg M, Jansson L, Ketolainen J, Pihlajamaki H, Suuronen R, et al. (2009) CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells. Stem Cell Res 2: 113-124.
17. Ng VY, Ang SN, Chan JX, Choo AB, (2010) Characterization of epithelial cell adhesion molecule as a surface marker on undifferentiated human embryonic stem cells. Stem Cells 28: 29-35.
18. Lu TY, Lu RM, Liao MY, Yu J, Chung CH, et al. (2010) Epithelial cell adhesion molecule regulation is associated with the maintenance of the undifferentiated phenotype of human embryonic stem cells. J Biol Chem 285: 8719-8732.
19. Henderson JK, Draper JS, Baillie HS, Fishel S, Thomson JA, et al. (2002) Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 20: 329-337.